IBDEI159 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19464,0)
 ;;=L21.9^^84^918^263
 ;;^UTILITY(U,$J,358.3,19464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19464,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,19464,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,19464,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,19465,0)
 ;;=L23.7^^84^918^30
 ;;^UTILITY(U,$J,358.3,19465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19465,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,19465,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,19465,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,19466,0)
 ;;=L23.9^^84^918^31
 ;;^UTILITY(U,$J,358.3,19466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19466,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,19466,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,19466,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,19467,0)
 ;;=L24.9^^84^918^163
 ;;^UTILITY(U,$J,358.3,19467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19467,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,19467,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,19467,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,19468,0)
 ;;=L25.9^^84^918^115
 ;;^UTILITY(U,$J,358.3,19468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19468,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,19468,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,19468,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,19469,0)
 ;;=L26.^^84^918^148
 ;;^UTILITY(U,$J,358.3,19469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19469,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,19469,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,19469,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,19470,0)
 ;;=L27.0^^84^918^265
 ;;^UTILITY(U,$J,358.3,19470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19470,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,19470,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,19470,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,19471,0)
 ;;=L27.1^^84^918^266
 ;;^UTILITY(U,$J,358.3,19471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19471,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,19471,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,19471,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,19472,0)
 ;;=L29.0^^84^918^250
 ;;^UTILITY(U,$J,358.3,19472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19472,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,19472,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,19472,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,19473,0)
 ;;=L29.9^^84^918^251
 ;;^UTILITY(U,$J,358.3,19473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19473,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,19473,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,19473,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,19474,0)
 ;;=L30.0^^84^918^232
 ;;^UTILITY(U,$J,358.3,19474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19474,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,19474,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,19474,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,19475,0)
 ;;=L30.1^^84^918^140
 ;;^UTILITY(U,$J,358.3,19475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19475,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,19475,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,19475,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,19476,0)
 ;;=L30.2^^84^918^132
 ;;^UTILITY(U,$J,358.3,19476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19476,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,19476,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,19476,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,19477,0)
 ;;=L30.4^^84^918^144
 ;;^UTILITY(U,$J,358.3,19477,1,0)
 ;;=^358.31IA^4^2
